Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
01/2003
01/29/2003EP1278738A2 The oxidation of ketones to esters using a tin substituted zeolite beta
01/29/2003EP1030836B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
01/29/2003EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
01/29/2003CN1394142A Use of cyclic ether for preparation of medicaments affecting glucose tolerance
01/28/2003US6512006 Novel 3-position Nitrogen substituted 6,6- disubstituted-5, 6-dihydropyrones and related compounds possess antiviral properties
01/28/2003US6511942 Animal husbandry, veterinary medicine
01/23/2003WO2003006454A2 Heterocyclic carboxamides and their use as fungicides
01/23/2003WO2003006451A1 4-phenylpyran-2-one derivatives
01/23/2003WO2002055491A3 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
01/23/2003WO2002008177A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
01/23/2003US20030018199 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
01/23/2003US20030018070 Bisaryl compound and medicament for cancer treatment comprising the same
01/23/2003US20030018013 Cardiovascular disorders; antilipemic agents; Alzheimer's disease
01/23/2003CA2418173A1 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
01/22/2003EP1277751A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277750A1 Hydrates and crystals of a neuraminic acid compound
01/22/2003EP1277749A1 2- and 2,5-substituted phenylketo enols
01/22/2003EP1277735A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277734A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277733A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1276741A1 Phenyl substituted 4-hydroxy tetrahydropyridone
01/22/2003EP0729465B1 Pyrone derivatives as protease inhibitors and antiviral agents
01/22/2003CN1392140A Organic compound with di-4-dicyan methyl olefine pyranoid ring and its synthetic method and use
01/22/2003CN1099420C Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2-4,-dione derivatives, methods of preparing them and their use as pest-control agents
01/21/2003US6509505 Hydrogenation catalysts
01/21/2003US6509479 Process for the removal of a silyloxy protecting group from 4-silyloxy-tetrahydro-pyran-2-ones
01/21/2003US6509299 Controlling pests; insecticides, miticides, nematocides
01/21/2003US6509298 Arthropod-controlling composition
01/16/2003WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists
01/16/2003US20030013896 Reacting 4-haloacetoacetyl halide in a solvent and scandium trifluoromethanesulfonate (a Lewis acid) and then hydrolyzed to form pyrone derivative
01/16/2003US20030013725 Amino acid derivatives
01/15/2003EP1275301A1 Trisubstituted heterocyclic compounds and their use as fungicides
01/15/2003EP1274422A1 Method for treating cells resistant to antineoplastic agents
01/15/2003EP0790989B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
01/15/2003CN1390838A Pyrone compounds and their use
01/14/2003US6506929 Process to manufacture simvastatin and intermediates
01/14/2003US6506911 Pyrano [3,2-d]-1,3-dioxin-8 ones
01/14/2003US6506910 Process for preparing discodermolide and analogues thereof
01/14/2003US6506387 Method for preparing aloin by extraction
01/09/2003WO2003002255A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts
01/09/2003US20030008868 Compounds useful as anti-inflammatory agents
01/09/2003US20030008856 Treatment of septic shock
01/09/2003US20030008849 For therapy of diseases mediated by TNF- alpha , such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss
01/08/2003EP0984934B1 Novel orally active iron (iii) chelators
01/08/2003CN1098255C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity
01/07/2003US6504036 2- and 2.5-substituted phenylketoenols
01/03/2003WO2003000673A2 Process for the preparation of simvastatin
01/03/2003WO2002060911A3 C-glucosyl ether lipids
01/03/2003WO2002051828A3 Novel c-glycoside derivatives and use thereof
01/02/2003US20030004359 Processes for producing tetrahydropyranyl-4-sulfonates and 4-aminotetrahydropyran compound
01/02/2003US20030004151 Cyclic derivatives as modulators of chemokine receptor activity
01/02/2003EP1268463A2 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
01/02/2003EP1268462A1 A process for producing simvastatin
01/02/2003EP1268397A2 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof
01/02/2003EP1115716B1 2-phenylpyran-4-one derivatives
01/02/2003EP0937718B1 Antibiotic tkr2648 and process for producing the same
01/01/2003CN1388117A Process for prodcing 3-aryl sulfate iso-hydroximic acid
12/2002
12/31/2002US6500963 Reacting a racemic mixture of 5,6-dihydro-4-hydroxy-2-pyrones with a chiral amino alcohol to resolve; use as chemical intermediates to anti-hiv drug tipranavir
12/31/2002US6500825 Substituted 2-aminoacetamides and the use thereof
12/27/2002WO2002070473A3 Carboxamide derivatives as therapeutic agents
12/26/2002US20020198390 Acrylic esters containing fluorine at alpha-position and having a lactone ring introduced into the ester side chain thereof; useful as monomers to produce base polymers for use in chemically amplified resist compositions
12/26/2002US20020198389 Process for preparing discodermolide and analogues thereof
12/26/2002US20020198383 For use in regioselective and enantioselective alkylations of allylic substrates
12/26/2002US20020198200 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators
12/26/2002US20020198158 A cyclic ether conatining atleast 3 carbon atoms; sugars; useful as antidiabetic agents
12/26/2002US20020197294 Pyrone compounds and there use
12/25/2002CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/24/2002US6498168 Muscarinic antagonists
12/19/2002WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002WO2002100323A2 METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS
12/19/2002WO2002070541A3 Peptide deformylase inhibitors
12/19/2002US20020193622 For use as additives in chemical amplification photolithography, photoresists
12/19/2002US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands
12/19/2002US20020193269 As precursors for organoleptic agents, such as fragrances, and masking agents and for antimicrobial agents
12/19/2002CA2450617A1 Methyl analogs of simvastatin as novel hmg-coa reductase inhibitors
12/18/2002EP1265884A1 A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
12/18/2002EP1265864A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
12/18/2002EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002EP1265838A1 Novel fatty acid analogous
12/18/2002EP1265604A1 Process for recovering statin compounds from a fermentation broth
12/17/2002US6495678 Immunosuppressant containing glucopyranose derivative as active ingredient
12/17/2002US6495594 Biologically active analogs of discodermolide
12/12/2002WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
12/12/2002US20020188136 Pesticides and herbicides
12/12/2002US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002US20020187531 Process for recovering statin compounds from a fermentation broth
12/12/2002CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
12/12/2002CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/11/2002EP1263979A1 Method of purifying a fermentation broth
12/11/2002EP1263427A1 Il-8 receptor antagonists
12/11/2002EP1032572B1 Pyranones, method for the production and use thereof
12/11/2002CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/10/2002US6492513 Method for separating a lactone-containing high-molecular weight compound having an alkyl group as its side chain from a lactone-containing high-molecular weight compound having an alkenyl group as its side chain, said lactone-containing
12/10/2002US6492393 Compounds useful as anti-inflammatory agents
12/10/2002US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002US6492362 Compounds and compositions as cathepsin S inhibitors
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 129